A Biomarker Out of Context: Understanding High p-tau217 in the Developing Brain

Area of Science:

• Neuroscience
• Biochemistry
• Developmental Biology

Background:

• Phosphorylated tau at threonine 217 (p-tau217) is a specific Alzheimer's biomarker in adults, linked to neurodegeneration.
• Elevated p-tau217 levels are paradoxically found in healthy neonates and infants without neurodegeneration.

Purpose of the Study:

• To investigate the physiological role of p-tau217 during early brain development.
• To differentiate p-tau217 as a developmental marker versus a pathological marker.
• To explain age-dependent tau biomarker profiles.

Main Methods:

• Literature review integrating clinical, biochemical, and developmental neuroscience data.
• Comparative analysis of tau biology in neonates and adults.
• Examination of tau isoforms, phosphorylation, clearance, and BBB permeability.

Main Results:

• High p-tau217 in infancy may indicate normal neurodevelopmental processes like axonal growth and synaptogenesis.
• Differential expression of tau isoforms, phosphorylation rates, and BBB permeability contribute to age-dependent biomarker profiles.
• Context-dependent regulation distinguishes p-tau217's role in development versus pathology.

Conclusions:

• p-tau217 may serve as a developmental marker in infants, distinct from its pathological role in adults.
• Age-specific biomarker frameworks are essential for accurate interpretation across the lifespan.
• Understanding tau physiology in development could lead to novel therapies for tauopathies.